Kumar R, O'Brien P Q, Thompson G K. "一种的合成方法" [P]. US Patent, US 11570376 B2, 2020-11-15.
Klinger H, Brown S R, Park J H. "Method for the Synthesis of 2-(3-Chlorophenyl)-2'-oxospiro[cyclopropane-1,3'-indoline]-5'-carboxylic acid" [P]. US Patent, US 10760687 B2, 2019-04-24.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2021, 917, (3), 280-300.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2020, 1315, (4), 8614-8620.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 2-(3-Chlorophenyl)-2'-oxospiro[cyclopropane-1,3'-indoline]-5'-carboxylic acid Using HRMS and NMR". Talanta, 2018, 459, (1), 1884-1910.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2025, 809, (5), 2713-2742.